BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 11987835)

  • 21. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
    Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study.
    Willich SN; Müller-Nordhorn J; Kulig M; Binting S; Gohlke H; Hahmann H; Bestehorn K; Krobot K; Völler H;
    Eur Heart J; 2001 Feb; 22(4):307-13. PubMed ID: 11161949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes.
    Roe MT; Chen AY; Mehta RH; Li Y; Brindis RG; Smith SC; Rumsfeld JS; Gibler WB; Ohman EM; Peterson ED
    Circulation; 2007 Sep; 116(10):1153-61. PubMed ID: 17709638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey.
    McGee HM; Doyle F; Conroy RM; De La Harpe D; Shelley E
    BMC Health Serv Res; 2006 Feb; 6():9. PubMed ID: 16476160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computerised systematic secondary prevention in ischaemic heart disease: a study in one practice.
    Starkey C; Michaelis J; de Lusignan S
    Public Health; 2000 May; 114(3):169-75. PubMed ID: 10878743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.
    Diercks DB; Roe MT; Mulgund J; Pollack CV; Kirk JD; Gibler WB; Ohman EM; Smith SC; Boden WE; Peterson ED
    Am Heart J; 2006 Jul; 152(1):140-8. PubMed ID: 16824844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Secondary prevention following coronary intervention. Survey of 13 intervention centers in Austria].
    Drexel H; Gaul GB; Grimm G; Klein W; Kleemann L; Leisch F; Mlczoch J; Pichler M; Sailer S; Slany J; Steinbach K; Tragl KH; Mori M; Kühn P
    Wien Klin Wochenschr; 1999 Sep; 111(16):643-9. PubMed ID: 10510842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Two year follow-up of acute ischemic syndrome without ST elevation].
    Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction.
    Foody JM; Ferdinand FD; Galusha D; Rathore SS; Masoudi FA; Havranek EP; Nilasena D; Radford MJ; Krumholz HM
    Circulation; 2003 Sep; 108 Suppl 1():II24-8. PubMed ID: 12970203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
    Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
    Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Profile of risk factors modification after coronary revascularization in patients with coronary artery disease].
    Nie SP; Liu XH; Du X; Kang JP; Lü Q; Dong JZ; Gu CX; Huang FJ; Zhou YJ; Li ZZ; Chen F; Lü SZ; Wu XS; Ma CS
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1097-101. PubMed ID: 16796833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.
    Blomkalns AL; Chen AY; Hochman JS; Peterson ED; Trynosky K; Diercks DB; Brogan GX; Boden WE; Roe MT; Ohman EM; Gibler WB; Newby LK;
    J Am Coll Cardiol; 2005 Mar; 45(6):832-7. PubMed ID: 15766815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.